Association of HLA-DR1 with the allergic response to the major mugwort pollen allergen: molecular background

BMC Immunology

Beatrice Jahn-Schmid²  Barbara Bohle¹  Wolfgang Schreiner⁶  Christof Ebner⁴  Bernard Maillere⁵  Ingrid Fae³  Dries Van Hemelen²  Gottfried Fischer³  Bernhard Knapp⁶ 

[1]Christian-Doppler Laboratory for Immunomodulation, Medical University of Vienna, Vienna, Austria

[2]Department of Pathophysiology and Allergy Research, Medical University of Vienna, Vienna, Austria

[3]Department of Blood Group Serology, Medical University of Vienna, Vienna, Austria

[4]Allergieambulatorium Reumannplatz, Vienna, Austria

[5]CEA, iBiTecS, Service d’Ingénierie Moléculaire des Protéines (SIMOPRO), Gif-sur-Yvette, France

[6]Department for Biomedical Computersimulation and Bioinformatics, Medical University of Vienna, Vienna, Austria

关键词: Molecular dynamics simulation;    Art v 1;    Allergen;    T cell recognition;    Peptide/MHC-class II-TCR interaction;    HLA association;   

Others  :  1077889
DOI  :  10.1186/1471-2172-13-43

 received in 2012-05-15, accepted in 2012-08-02,  发布年份 2012

【 摘 要 】

Background

Mugwort pollen allergens represent the main cause of pollinosis in late summer. The major allergen, Art v 1, contains only one single immunodominant, solely HLA-DR-restricted T cell epitope (Art v 1_25-36). The frequency of HLA-DRB1*01 is highly increased in mugwort-allergic individuals and HLA-DR1 serves as restriction element for Art v 1_25-36. However, Art v 1_25-36 also binds to HLA-DR4 with high affinity and DR1-restricted Art v 1_25-36 -specific T cell receptors can be activated by HLA-DR4 molecules. To understand the predominance of HLA-DR1 in mugwort allergy in spite of the degeneracy in HLA/peptide-binding and TCR-recognition, we investigated the molecular background of Art v 1_25-36 /MHC/TCR interactions in the context of HLA-DR1 compared to -DR4.

Results

The majority of Art v 1_25-36 -specific T cell lines and clones from HLA-DR1 carrying, mugwort pollen-allergic donors reacted to synthetic and naturally processed Art v 1–peptides when presented by HLA-DR1 or HLA-DR4 expressing antigen presenting cells. However, at limiting peptide concentrations DR1 was more effective in T cell stimulation. In addition, the minimal epitope for 50% of Art v 1_25-36 -specific T cells was shorter for DR1 than for DR4. In vitro binding assays of Art v 1_25-36 mutant peptides to isolated DR1- and DR4-molecules indicated similar binding capacities and use of the same register. In silico simulation of Art v 1_25-36 binding to HLA-DR1 and -DR4 suggested similar binding of the central part of the peptide to either molecule, but a higher flexibility of the N- and C-terminal amino acids and detachment at the C-terminus in HLA-DR1.

Conclusions

The predominance of HLA-DR1 in the response to Art v 1_25-36 may be explained by subtle conformation changes of the peptide bound to DR1 compared to DR4. Computer simulation supported our experimental data by demonstrating differences in peptide mobility within the HLA-DR complex that may influence TCR-binding. We suggest that the minor differences observed in vitro may be more relevant in the microenvironment in vivo, so that only presentation by HLA-DR1, but not -DR4 permits successful T cell activation.

【 授权许可】

   
2012 Knapp et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

Figure 5.

【 参考文献 】

• [1]Romagnani S: The role of lymphocytes in allergic disease. J Allergy Clin Immunol 2000, 105:399-408.
• [2]Hammer J, Valsasnini P, Tolba K, Bolin D, Higelin J, Takacs B, Sinigaglia F: Promiscuous and allele-specific anchors in HLA-DR-binding peptides. Cell 1993, 74:197-203.
• [3]Panina-Bordignon P, Tan A, Termijtelen A, Demotz S, Corradin G, Lanzavecchia A: Universally immunogenic T cell epitopes: promiscuous binding to human MHC class II and promiscuous recognition by T cells. Eur J Immunol 1989, 19:2237-2242.
• [4]Wilson DB, Wilson DH, Schroder K, Pinilla C, Blondelle S, Houghten RA, Garcia KC: Specificity and degeneracy of T cells. Mol Immunol 2004, 40:1047-1055.
• [5]Ou D, Mitchell LA, Tingle AJ: HLA-DR restrictive supertypes dominate promiscuous T cell recognition: association of multiple HLA-DR molecules with susceptibility to autoimmune diseases. J Rheumatol 1997, 24:253-261.
• [6]Himly M, Jahn-Schmid B, Dedic A, Kelemen P, Wopfner N, Altmann F, van Ree R, Briza P, Richter K, Ebner C, et al.: Art v 1, the major allergen of mugwort pollen, is a modular glycoprotein with a defensin-like and a hydroxyproline-rich domain. Faseb J 2003, 17:106-108.
• [7]Jahn-Schmid B, Kelemen P, Himly M, Bohle B, Fischer G, Ferreira F, Ebner C: The T cell response to Art v 1, the major mugwort pollen allergen, is dominated by one epitope. J Immunol 2002, 169:6005-6011.
• [8]Jahn-Schmid B, Fischer GF, Bohle B, Fae I, Gadermaier G, Dedic A, Ferreira F, Ebner C: Antigen presentation of the immunodominant T-cell epitope of the major mugwort pollen allergen, Art v 1, is associated with the expression of HLA-DRB1 *01. J Allergy Clin Immunol 2005, 115:399-404.
• [9]Jahn-Schmid B, Pickl WF, Bohle B: Interaction of allergens, major histocompatibility complex molecules, and T cell receptors: a 'menage a trois' that opens new avenues for therapeutic intervention in type I allergy. Int Arch Allergy Immunol 2011, 156:27-42.
• [10]Jahn-Schmid B, Sirven P, Leb V, Pickl WF, Fischer GF, Gadermaier G, Egger M, Ebner C, Ferreira F, Maillere B, et al.: Characterization of HLA class II/peptide-TCR interactions of the immunodominant T cell epitope in Art v 1, the major mugwort pollen allergen. J Immunol 2008, 181:3636-3642.
• [11]Southwood S, Sidney J, Kondo A, del Guercio MF, Appella E, Hoffman S, Kubo RT, Chesnut RW, Grey HM, Sette A: Several common HLA-DR types share largely overlapping peptide binding repertoires. J Immunol 1998, 160:3363-3373.
• [12]Grunewald J, Shankar N, Wigzell H, Janson CH: An analysis of alpha/beta TCR V gene expression in the human thymus. Int Immunol 1991, 3:699-702.
• [13]He X, Rosloniec EF, Myers LK, McColgan WL, 3rd Gumanovskaya M, Kang AH, Stuar JM: T cell receptors recognizing type II collagen in HLA-DR-transgenic mice characterized by highly restricted V beta usage. Arthritis Rheum 2004, 50:1996-2004.
• [14]Texier C, Pouvelle S, Busson M, Herve M, Charron D, Menez A, Maillere B: HLA-DR restricted peptide candidates for bee venom immunotherapy. J Immunol 2000, 164:3177-3184.
• [15]Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res 2000, 28:235-242.
• [16]Zavala-Ruiz Z, Strug I, Walker BD, Norris PJ, Stern LJ: A hairpin turn in a class II MHC-bound peptide orients residues outside the binding groove for T cell recognition. Proc Natl Acad Sci U S A 2004, 101:13279-13284.
• [17]Knapp B, Omasits U, Schreiner W: Side chain substitution benchmark for peptide/MHC interaction. Protein Sci 2008, 17:977-982.
• [18]Canutescu AA, Shelenkov AA, Dunbrack RL: Jr.: A graph-theory algorithm for rapid protein side-chain prediction. Protein Sci 2003, 12:2001-2014.
• [19]Knapp B, Omasits U, Frantal S, Schreiner W: A critical cross-validation of high throughput structural binding prediction methods for pMHC. J Comput Aided Mol Des 2009, 23:301-307.
• [20]Hess B, Kutzner C, VanderSpoel D, Lindahl E: GROMACS 4: Algorithms for Highly Efficient, Load-Balanced, and Scalable Molecular Simulation. J Chem Theory Comput 2008, 4:435-447.
• [21]Karplus M, McCammon JA: Molecular dynamics simulations of biomolecules. Nat Struct Biol 2002, 9:646-652.
• [22]Omasits U, Knapp B, Neumann M, Steinhauser O, Stockinger H, Kobler R, Schreiner W: Analysis of Key Parameters for Molecular Dynamics of pMHC Molecules. Mol Simulat 2008, 34:781-793.
• [23]Lee B, Richards FM: The interpretation of protein structures: estimation of static accessibility. J Mol Biol 1971, 55:379-400.
• [24]Shrake A, Rupley JA: Environment and exposure to solvent of protein atoms. Lysozyme and insulin. J Mol Biol 1973, 79:351-371.
• [25]Humphrey W, Dalke A, Schulten K: VMD: visual molecular dynamics. J Mol Graph 1996, 14:33-38. 27-28
• [26]Knapp B, Lederer N, Omasits U, Schreiner W: vmdICE: a plug-in for rapid evaluation of molecular dynamics simulations using VMD. J Comput Chem 2010, 31:2868-2873.
• [27]Sette A, Sidney J, Oseroff C, del Guercio MF, Southwood S, Arrhenius T, Powell MF, Colon SM, Gaeta FC, Grey HM: HLA DR4w4-binding motifs illustrate the biochemical basis of degeneracy and specificity in peptide-DR interactions. J Immunol 1993, 151:3163-3170.
• [28]Baker D, Sali A: Protein structure prediction and structural genomics. Science 2001, 294:93-96.
• [29]Ehrenmann F, Kaas Q, Lefranc MP: IMGT/3Dstructure-DB and IMGT/DomainGap Align: a database and a tool for immunoglobulins or antibodies, T cell receptors, MHC, IgSF and MhcSF. Nucleic Acids Res 2010, 38:D301-D307.
• [30]Chicz RM, Urban RG, Lane WS, Gorga JC, Stern LJ, Vignali DA, Strominger JL: Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogeneous in size. Nature 1992, 358:764-768.
• [31]Mutschlechner S, Egger M, Briza P, Wallner M, Lackner P, Karle A, Vogt AB, Fischer GF, Bohle B, Ferreira F: Naturally processed T cell-activating peptides of the major birch pollen allergen. J Allergy Clin Immunol 2010, 125:711-718. 718 e1-718 e2
• [32]Kropshofer H, Vogt AB, Moldenhauer G, Hammer J, Blum JS, Hammerling GJ: Editing of the HLA-DR-peptide repertoire by HLA-DM. Embo J 1996, 15:6144-6154.
• [33]Reinherz EL, Tan K, Tang L, Kern P, Liu J, Xiong Y, Hussey RE, Smolyar A, Hare B, Zhang R, et al.: The crystal structure of a T cell receptor in complex with peptide and MHC class II. Science 1999, 286:1913-1921.
• [34]Knapp B, Omasits U, Bohle B, Maillere B, Ebner C, Schreiner W, Jahn-Schmid B: 3-Layer-based analysis of peptide-MHC interaction: in silico prediction, peptide binding affinity and T cell activation in a relevant allergen-specific model. Mol Immunol 2009, 46:1839-1844.
• [35]Knapp B, Omasits U, Schreiner W, Epstein MM: A comparative approach linking molecular dynamics of altered peptide ligands and MHC with in vivo immune responses. PLoS One 2010, 5:e11653.